Clinical Research Directory
Browse clinical research sites, groups, and studies.
Theranostic Applications of Radionuclides in Prostate Cancer
Sponsor: Guilin Medical University, China
Summary
The objective of the study is to construct a noninvasive approach ACP3 targeted PET/CT to detect tumor lesions in patients with prostate cancer and to compare with PSMA/FDG PET/CT.
Official title: ACP3 Targeted -PET/ CT in Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-01-01
Completion Date
2029-12-31
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT
Each subject receives a single intravenous injection of standard-of-care imaging radiopharmaceutical (PSMA/FDG) and ACP3, and undergoes PET/CT imaging within the specified time.
Locations (1)
The First Affliated Hospital of Guilin Medical University
Guilin, Guangxi, China